NASDAQ:CLOV

Clover Health Investments Stock News

etoro logo Buy CLOV
*Your capital is at risk
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earning
Clover Health's third-quarter 2024 results continue to benefit from the strength of its business model.
Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.09 per share a year ago.
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer
Clover Health's pivot to profitability over growth following the divestiture of the non-insurance segment at the end of 2023 has led to significant earnings improvements. The newly launched Counterpar
The continued strength in Clover Health's offerings is likely to have driven the company's performance in the third quarter.
FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after
Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating
Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience Overall Star rating performance increase was d
Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Hea
Chamath Palihapitiya is a prominent venture capitalist, engineer, and entrepreneur known for his significant contributions to the tech sector.
The 'Undercovered' Dozen highlights 12 lesser-covered stocks with strong potential, aiming to provide investment ideas and spark community discussion. Dmytro Konovalov takes a look at the impacts of T
Clover Health Investments (CLOV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
While special purpose acquisition companies (SPACs) have been around for years, they really burst onto the mainstream investor's consciousness in 2020.
New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients New Jersey Native Joseph Brand to Lead Operational Efficiency
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE